Literature DB >> 18583959

Induction of a pro-apoptotic ATM-NF-kappaB pathway and its repression by ATR in response to replication stress.

Zhao-Hui Wu1, Shigeki Miyamoto.   

Abstract

The transcription factor NF-kappaB has critical functions in biologic responses to genotoxic stimuli. Activation of NF-kappaB in response to DNA double strand break (DSB) inducers can be mediated by ATM (ataxia telangiectasia mutated)-dependent phosphorylation of NEMO (NF-kappaB essential modulator). Here, we show that the replication stress inducers hydroxyurea (HU) and aphidicolin also activate this ATM-dependent signalling pathway. We further show that ATR (ATM- and Rad3-related) interacts with NEMO but surprisingly does not cause NEMO phosphorylation. Consequently, ATR represses NF-kappaB activation induced by replication stress. Reduction or increase of ATR expression by RNA interference or overexpression increased or reduced ATM-NEMO association and NF-kappaB activation induced by HU. Apoptosis gene expression and chromatin immunoprecipitation analyses indicated that HU and the DSB inducer etoposide caused complex patterns of NF-kappaB-dependent pro- and antiapoptotic gene expression with the overall outcome for the former being pro-apoptotic, whereas the latter antiapoptotic. Thus, replication stress and DSB inducers activate NF-kappaB through a conserved pathway with opposite biologic outcomes, and ATR antagonizes ATM function at least in part by competing for NEMO association.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583959      PMCID: PMC2486281          DOI: 10.1038/emboj.2008.127

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?

Authors:  D Durocher; S P Jackson
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

Review 3.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 4.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

Review 5.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 6.  Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation.

Authors:  Tracy Criswell; Konstantin Leskov; Shigeki Miyamoto; Guangbin Luo; David A Boothman
Journal:  Oncogene       Date:  2003-09-01       Impact factor: 9.867

7.  ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks.

Authors:  N Li; S Banin; H Ouyang; G C Li; G Courtois; Y Shiloh; M Karin; G Rotman
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

8.  Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.

Authors:  Tony T Huang; Shelly M Wuerzberger-Davis; Zhao-Hui Wu; Shigeki Miyamoto
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

9.  53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer.

Authors:  Richard A DiTullio; Tamara A Mochan; Monica Venere; Jirina Bartkova; Maxwell Sehested; Jiri Bartek; Thanos D Halazonetis
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

10.  Interplay between ATM and ATR in the regulation of common fragile site stability.

Authors:  E Ozeri-Galai; M Schwartz; A Rahat; B Kerem
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

View more
  41 in total

1.  MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN.

Authors:  Guangyun Tan; Yuling Shi; Zhao-Hui Wu
Journal:  Biochem Biophys Res Commun       Date:  2011-12-07       Impact factor: 3.575

2.  The importance of the p50 NF-κB subunit.

Authors:  Neil D Perkins
Journal:  Cell Cycle       Date:  2015-08-20       Impact factor: 4.534

Review 3.  Nuclear initiated NF-κB signaling: NEMO and ATM take center stage.

Authors:  Shigeki Miyamoto
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

4.  Small molecule derived from a natural product that mitigates radiation injury.

Authors:  Philip P Connell; Ralph R Weichselbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-01       Impact factor: 11.205

5.  NF-κB-dependent microRNA-125b up-regulation promotes cell survival by targeting p38α upon ultraviolet radiation.

Authors:  Guangyun Tan; Jixiao Niu; Yuling Shi; Hongsheng Ouyang; Zhao-Hui Wu
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

Review 6.  Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.

Authors:  David R Raleigh; Daphne A Haas-Kogan
Journal:  Future Oncol       Date:  2013-02       Impact factor: 3.404

7.  NF-κB potentiates caspase independent hydrogen peroxide induced cell death.

Authors:  Jessica Q Ho; Masataka Asagiri; Alexander Hoffmann; Gourisankar Ghosh
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

8.  Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation.

Authors:  Hyungshin Yim; Raymond L Erikson
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

9.  Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells.

Authors:  Xu Zhu; Robert M Straubinger; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-08       Impact factor: 2.745

10.  Expanding the substantial interactome of NEMO using protein microarrays.

Authors:  Beau J Fenner; Michael Scannell; Jochen H M Prehn
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.